Janux Therapeutics, Inc. (JANX)
15.31
+0.47
(+3.17%)
USD |
NASDAQ |
Apr 06, 14:45
Janux Therapeutics Total Assets (Quarterly) : 1.008B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 90.04B |
| EyePoint Plc | 364.00M |
| CorMedix, Inc. | 877.63M |
| ADMA Biologics, Inc. | 633.35M |
| Viking Therapeutics, Inc. | 715.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.70M |
| Shareholders Equity (Quarterly) | 956.82M |
| Debt to Equity Ratio | 0.0231 |
| Current Ratio | 39.04 |
| Net Debt Paydown Yield | 0.03% |